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Among the oxidases, amine- oxidase shows some 
suggestive peculiarities regarding its suscepti- 
bility to enzyme poisons; it is cyanide insensitive, 
and inhibited by, narcotics, but not by reducing 
agents such as ascorbic acid. It is also inhibited 
by ephedrine, cocaine and other local anaesthetics. 
Catechol oxidase, on the other hand, is very sensitive 
to cyanide, inhibited by ascorbic acid but not by 
ephedrine or cocaine. Nevertheless most of the 
,4fAndiñgs are in favour of the hypothesis that 
adrenaline is destroyed in the body by amine- oxidase. 
But there are some points against it; firstly, that 
the rate of action of amine oxidase in vitro is too 
slow to account for the rapid inactivation of 
adrenaline in the body; secondly, that adrenaline 
is inactivated in tissues such as rabbit's ears 
which do not contain amine -oxidase (Gaddum and 
Kwiatkowski, 1938; a*4 Richter, 1940). 
The liver is the chief tissue which contains 
considerable quantities of amine -oxidase and 
hepatectomy does not alter the rate of inactivation 
of adrenaline in dogs (Markowitz and Mann, 1922). 
Similar objections can be raised against the view 
that phenol oxidase is responsible for the inacti- 
vation/ 
vation of adrenaline in vivo. Mammalian tissues 
have been shown to possess very little activity 
(Duchateau- Bosson and Florkin, 1239). Moreover in 
some lower animals no relationship was found between 
the phenolase activity and the distribution of.t:h.e 
chromaffin system. For example arthropods which .
show a high phenolase activity have no chromaffin 
system, whereas annelida which have a well defined 
chromaffin system show very little phenolase acti- 
vity. (Bhagvat and Richter, 1938). 
Clark and Raventos (1939) showed that the 
inactivation of adrenaline by frog's auricle was 
inhibited by ascorbic acid. This would agree with 
the view that adrenaline inactivation in the body 
is due to cytochrome oxidase which is known to be 
present in all the tissues. De Meio and Luduena 
(1940) found that the slow inactivation of adrenaline 
by dog's retractor penis muscle (10-50 per cent. 
in 2 -5 hours) was not inhibited by cyanide (1-2 times 
10 
3 
molar), a concentration which would certainly 
inhibit cytochrome oxidase. 
Clark and Raventos (1939) calculated the rate 
of clearance of adrenaline in the intact cat from 
the relation between the dosage and duration of 
action/ 
-4 - 
action of the drug. They found that for doses of 
adrenaline below 3 ..g /kg. the time of half clearance 
was constant, but with doses above 3 µg /kg. a 
constant amount of the drug was destroyed in a unit 
of time. These results suggest saturation of the 
inactivating enzyme with doses of adrenaline above 
3 µg /kg. 
The work here described was an attempt to 
study the nature of the mode of clearance of 
adrenaline by continuous infusion of the drug, and 
the influence of certain enzyme inhibitors on the 
action and rate of clearance of adrenaline. 
The extensive literature on the inactivation 
of adrenaline has been reviewed and S. brief account 
of the history and chemistry of the drug is given. 
ADREIULI]aTß.. ; 
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U. ADRENALINE - historical and Chemistry. 
historical. 
Adrenaline was the first of all the hormones to 
be fully identified chemically. In 1856 Vulpian 
discovered "chromaffin substance" in the medulla of 
the suprarenal glands and in association with some 
other sympathetic cells. The pressor effect of the 
suprarenal extracts was first demonstrated by Oliver 
and Schafer (1895), by injecting these extracts intra- 
venously into cats and other mammals. This observa- 
tion was soon followed by attempts to isolate the 
active principle of the suprarenal medullary extract. 
Abel (1898) isolated an impure form which he called 
epinephrine. Some years later Takamine (1901) 
and Aldrich (1901) isolated the active principle 
in a pure crystalline form and named it adrenaline. 
In 1904 Jowett determined its structure and in the 
same year the synthesis was accomplished (Stolz, 1904, 
Dakin, 1904), and later an extensive series of re- 
lated amines were synthesized (Barger and Jowett, 
1905; Barger and Dale, 1910) . 
Chemistry. 
Adrenaline is a white crystalline substance. 
It is a weak base and forms salts with acids. 
Chemically it is dihydroxy phenyl ethanol methyl 
amine, with the structural formula: - 
H H H 
I 
IIt 1 
0-1 / OH H Cß+3 
oH 
-6- 
This corresponds to the empirical formula 
C9H13NO3 first suggested by Aldrich (19CI). 
Structurally adrenaline is closely related to 
tyrosine and it is thought that it may be e deriva- 
tive of this or similar amines present in the body. 
The laevo- rotatory form of adrenaline is about twelve 
times more active than the dextro- rotatory form. 
III. REVIEW OF THE LITTRATURE ON THE INACTIVATION 
OF ADRENALINE. 
A. In vitro. 
B. In vivo. 
A. in vitro. 
Catal-- tic action of physical and chemical agents. 
Adrenaline is readily oxidized in the presence 
of light and air, though simple boiling does not 
reduce its activity (Oliver and Schafer, 1895). The 
oxidation rate of adrenaline, by hydrogen peroxide 
and. potassium permanganate was shown to reach the 
maximum at a temperature of 35 °C. (Barker et al, 
1932). Suprarenal extracts and adrenaline solutions 
are more rapidly oxidized in alkaline than in acid 
or neutral solutions (Oliver and :chgfer, 1895; 
Blix, 19 29 ; Sugawara, 19 29 ; and Barker et a 1,19 32) . 
The presence of particles of heavy metals, such as 
copper/ 
n 
copper, iron, calcium, cobalt, nickel, silver, 
mercury, manganese etc. in solution of adrenaline 
catalyses the oxidation, copper being the most 
active (Barker et al, 1932; SchiOld, 1933; Welch, 
1934). 
Welch (1934) observed that the oxidation of 
very dilute solutions of adrenaline wa, catalysed 
even by coming in contact with ':a glass surface. 
Eugawara (1929) studied the rate of oxidation of 
adrenaline by aeration, in various physiological 
solutions, including defibrinated blood and distilled 
water. The approximate times of half inactivation 
calculated from his results are as follows; 
Redistilled water 74 hours 
Sodium chloride solution, 







These results show that the rate of oxidation of 
adrenaline in distilled water which does not contain 
any metallic ions, is very slow. Barker et al 
(1932) also found that the rate of oxidation of 
adrenaline/ 
-8 - 
adrenaline by hydrogen peroxide and potassium 
permanganate was more rapid in tap water than in 
distilled water. 
Cramer (19 11) was very interested by the 
specificity and rapidity with Nhich formaldehyde 
destroyed adrenaline in vitro; he found that 
adrenaline was completely destroyed when 5 c.c. of 
1/50,000 solutions vas incubated with formaldehyde 
(5 c.c. 1/500) in 4 to 5 minutes, and in a shorter 
time with smaller quantities of adrenaline. He 
suggested that the inactivation of adrenaline in the 
body was brought about not by a process of oxidation 
but by combination with metabolic products of cells 
on which the drug acted. Toscano -Rico and Malafaya 
Baptista (1935) concluded that the aldehyde formed 
as an intermediate product of carbohydrate metabolism 
was responsible for the inactivation of adrenaline 
in the body. 
Inactivation of adrenaline by living tissues. 
There is an extensive literature regarding the 
inactivation of adrenaline by e isolated tissues. 
Many authors in the late nineteenth and early 
twentieth century showed that several tissues 
possessed the power of inactivating adrenaline. 
Langlois (1897, 1898) found that suprarenal extracts 
were/ 
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were inactivated when ground with rabbit's liver 
or intestine, but not with lung. Similar results 
were obtained by perfusion of adrenaline through 
intestine and. lungs (Elliott, 1905) and through the 
liver (Livon, 1904; battelli, 1902) . Bain et al 
(1937) found that adrenaline was completely inacti- 
vated after being incubated with liver slices; they 
noted that this property of liver slices was 
diminished by dipping them into boiling water, and 
completely abolished by boiling for two minûtes. 
Geoffridi (1907) investigated the rate of inactivation 
of adrenaline by perfusing the drug through various 
organs. He found that the rate of inactivation was 
most rapid in the liver, moderate in the skeletal 
muscles and none in the lungs, kidneys or brain. he 
concludedthat the inactivation of adrenaline was a 
special function of the liver. Tatum (1912) incubated 
pieces of blood vessels with solutions of epinephrine 
and found that the solutions markedly lost their 
potency; while control solutions did not show much 
diminution. Lai +ren ( 1904) found that a considerable 
amount of epinephrine was lost after repeated 
perfusions of the solution of the drug through the 
hind limb of the frog. 
Results contradictory to those described above 
have/ 
-10- 
have been described by some authors. V,iltshire (1931) 
believes that the living, tissues do not destroy but 
protect adrenaline from oxidation in vitro. Embden 
and Furth (1904) stated that neither perfusion through 
the organs nor aeration in contact with the pounded 
tissues caused an appreciable amount of adrenaline 
to be inactivated. The contradictory results 
obtained by these authors, however, appear to be due 
to the enormous quantities of adrenaline (total dose 
50 mgm.) used in their perfusion experiments. 
Inactivation of adrenaline by blood. 
The fact that the activity of suprarenal extracts 
was not affected by mixing with dog's whole blood 
was first shown by Oliver and 6cháfer (1895) and 
later confirmed by many other authors ( Langlois, 1898; 
Embden and Furth, 1904). Bugawara (1928 -29), 
however, found that the inactivation of adrenaline 
by dog's defibrinated blood was stopped after an 
initial destruction of 60 per cent. in about 2 hours. 
Bain et al (1936a, 1936b, 1937) showed that 
adrenaline was destroyed both by the serum and 
plasma, the rate of destruction being twice as 
rapid/ 
rapid in the former as in the latter. They found 
that the destruction of adrenaline in both serum 
and plasma was complete, whereas in whole blood 
the process stopped after the equilibrium concen- 
tration of the drug was reached. They recovered 
80 per cent. of the original amount of adrenaline 
from the equilibrium mixture and showed that the 
drug in the whole blood was protected by the blood 
corpuscles; and concluded that blood itself was 
probably of small significance in determining the 
inactivation of adrenaline in the body, and that 
in tissues the conditions for this inactivation 
were fulfilled. 
Inactivation of adrenaline by enzyme systems. 
1. Amine- oxidase. 
The fact that many tissues inactivate 
adrenaline in vitro diverted the attention of the 
investigators towards the isolation of the inacti- 
vating substance or substances from various tissues. 
The work of Blaschko et al (1957a) showed that there 
was present in the liver, kidneys and small 
intestine/ 
-12- 
intestine of certain animals a cyanide -resistant 
substance which inactivated adrenaline in vitro. 
These workers incubated cell free extracts of liver, 
kidneys and small intestine from guinea pigs, rats 
and rabbits with adrenaline solutions and found that 
in the presence of oxygen they greatly accelerated 
the inactivation of the drug. They purified the 
inactivating enzyme (amine -oxidase) from the ex- 
tracts and found that, like other enzymes, it was 
thermolabile and noridialysable. Its action was 
inhibited by narcotics but not by cyanide and 
reducing agents, such as ascorbic acid and gluta- 
thione. Ephedrine, a sympathomimetic amine, though 
not affected by amine- oxidase,has been shown to 
inhibit the inactivation of adrenaline by this 
enzyme. (Richter and Tingey, 1939) . The protective 
against 
action of ephedrine mar adrenaline oxidation by 
amine -oxidase has been explained on the theory of 
substrate competition. 
Similar effects were found in vivo,and so it 
was suggested that amine -oxidase was probably the 
enzyme system that destroyed adrenaline or 
sympathin in the body (Gaddum and Kwiatkowski,1938). 
The amine -oxidase contents of various tissues vary 
in different species of animals. The livers of 
omnivorous/ 
-13- 
omnivorous animals contain less enzyme than the 
livers of herbivorous animals; the highest concen- 
tration is found in ruminants. Of all the tissues 
the liver contains the highest amount, while skeletal 
muscles, kidneys and spleen contain very little and 
rabbits' ears contain none (Blaschko et al, 19374, 
1937b; Richter and Tingey, 1939; Bhagvat et al, 
1939). In addition to adrenaline many other 
primary and secondary amines are inactivated by 
amine -oxidase in vitro. Extracts of kidney and 
liver have been shown by Pugh and Quastel (1937) 
to inactivate a number of aliphatic amines. 
The inactivation of adrenaline and related 
amines by amine -oxidase, has been shown to depend 
upon the molecular configuration of these compounds. 
Blaschko et al (193'7b)incubated guinea pig and rat's 
liver extracts after adding RCN (to exclude the 
action of other enzymes) with structurally related 
sympathomimetic amines (adreralone, adrenaline, p- 
sympatol, arterenol, epinine, laevo- etedrine and 
corbasil). They showed that only those compounds 
having configuration = C - CH2 - N = were oxidized 
by amine -oxidase. Compounds such as carbasil and 
ephedrine,which do not have this configuration,are 
not 
-14- 
not attacked by amine -oxidase. The oxidation of 
adrenaline by amine -oxidase occurs in the side 
chain of the molecule; the products of oxidation 
of amines by amine-oxidase are always an aldehyde 
and ammonia or a lower amine. 
-iccording to hichter (1937) the reaction 
in the case of adrenaline can be represented by the 
following equation:- 
HO / \CHOH. CH2NH2CH3 r 02 HO CHOH. CHO + 413 CH3 
HO v HO 
The relation between the molecular configuration 
of sympathomimetic amines and their oxidation by 
amine -oxidase has also been described by Beyer 
(1941) and Beyer and Vernon (1942) . They found 
that amine -oxidase obtained from the liver of guinea 
pig, rat or rabbit, oxidized only those phenyl - 
propylamines which had amino group attached to the 
terminal carbon atom of the side chain. Beyer and 
Vernon (1942) have shown that damaging of the liver 
in the animals by giving carbon tetrachloride or 
hydrazine prior to administration of compounds, which 
in vitro are oxidized by amine -oxidase, results in 
the excretion of these compounds in the same way as 
those which are not attacked by amine -oxidase, i.e. 
ephedrine/ 
-16 
enzyme and the chromaffin system in some animals. 
For example arthropods which do not have a chromaffin 
system were found to possess the highest phenolase 
activity. On the other hand lumbricus terrestris 
and Hirdu medicinalis, which have well defined 
chromaffin system, showed little phenolase activity. 
Catechol oxidase is thermolabile and very sensitive 
to cyanide (Kastle and, iJoevenhart, 1901) . It is 
inhibited by H2S, CO, and resorcinol (hichter 1934; 
Keilin, 1929; Keilin, 1936) but is not inhibited 
by methylene blue (Philpot, 1937). The oxidation 
of adrenaline by catechol oxidase is also inhibited 
by reducing substances, but is comparatively 
resistant to narcotics and other usual enzyme 
poisons (Richter, 1934). Keilin and kann (1938) 
prepared catechol oxidase from mushrooms and 
found that it was destroyed by alkalies and acids. 
They found that the enzyme consisted of the com- 
bination of protein and a metal (iron, copper or 
manganese, etc.), and that the active group of the 
enzyme always contained copper. Bhagvat and 
Richter (1938), who worked on the animal phenolases 
prepared from arthropods and molluscs, found that 
they/ 
they oxidized catechol derivatives. They also 
showed that the apparent activity in a number of 
arthropods and molluscs was mainly due to haemo- 
cyanins and other copper protein complexes, which 
acted as pseudo- phenolases. They obtained a 
crystalline copper protein complex from the blood 
of Cancer Pagus which was catalytically active. 
Beyer (1941) has shown that amino compounds having 
one or two hydroxyl groups on the benzene ring are 
oxidized by phenol oxidase. Bacq (1938) believes 
body by 
that adrenaline is oxidized in theXcatechol oxidase, 
and that during the oxidation of the drug by this 
enzyme, a substance with inhibitory properties 'is 
produced. Adrenochrome is formed in the course of the 
oxidation of adrenaline by phenol oxidase, and if this 
is the process of inactivation of adrenaline in the 
body, then it should be excreted in the urine in the 
conjugated form. Richter (1940), however, did not 
find any increase in the indol derivatives in the 
urine after oral administration of adrenaline in man. 
3. Cytochrome oxidase (indophenol oxidase) 
Cytochrome oxidase is known to be present in 
all tissues (Green and Richter, 1937; Keilin and 
hartree, 1938). The best source of this enzyme 
however/ 
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however is the heart muscle. Cytochrome oxidase is 
destroyed very rapidly by drying or by treatment 
with alcohol or acetone (Keilin and Hartree, 1938). 
Its catalytic activity is completely inhibited by 
N /100 HCN (Green and Richter, 1937; Keilin and 
Hartree, 1938), and by H2E, Nip and CO (Keilin and 
Hartree, 1938). It is not inhibited by methylene 
blue (Philpot and. Cantoni, 1941), and it has a great 
affinity for oxygen. In vitro it oxidizes adrenaline 
and a number of catechol derivatives. Adrenoch.rome 
is the product of oxidation by cytochrome oxidase. 
Philpot and Cantoni (1941) estimated the ratof 
oxidation of adrenaline by liver suspensions and by 
suspensions of dog's and rabbit's heart muscle. They 
found that cyanide M /100 completely inhibited the 
oxidation of adrenaline by heart muscle suspension, 
and only slightly inhibited the destruction of 
adrenaline by liver suspension. 
Keilin and Hartree (1938) obtained cytochrome 
oxidase from the heart muscle and found that the 
oxidation of adrenaline and e number of diamines 
and polyphenols by the enzyme system was greatly 
increased by the addition of M /100,000 to N /10,000 
cytochrome C. They concluded that cytochrome 
oxidase/ 
oxidase does not oxidize adrenaline and other com- 
pounds directly but through. the cooperation of 
cytochrome C. Clark and Raventos (1939) showed 
that isolated frog's auricle inactivated adrenaline 
and that this action was inhibited by the addition 
of ascorbic acid (10 -6 ). This observation supports 
the view that adrenaline in the body is inactivated 
by cytochrome oxidase which is known to be present 
in all the tissues. De Meio and Luduena (1940), 
however, found that the inactivation of adrenaline 
by dog's retractor penis muscle was not inhibited 
by cyanide which would have inhibited cytochrome 
oxidase. 
Rate of action of enzymes. 
The chief difficulty with regard to the 
inactivation of adrenaline by enzymes is that the 
rates of action found have been far slower than 
the rates of inactivation of adrenaline in the body. 
Rate of action of amine-oxidase: Richter and 
Tingey (1939) incubated liver suspensions containing 
100 units /c.c. of amine -oxidase, with adrenaline 
solutions of 104 - 10 -n, and found that half 
inactivation occurred in 30 minutes. This time 
would correspond to half clearance in the liver 
in/ 
-20- 
in 12 mins. and much slower clearance in other 
tissues which contain relatively little amine- 
oxidase. With adrenaline concentrations of 10 
only 10 p.c. was destroyed in 30 mins. These rates 
of destruction are far slower than the rates of 
inactivation of adrenaline in the body. Kohn (1937) 
found that amine -oxidase had a much lower affinity 
constant for adrenaline (K = 2 x 10 
-2 
) than for 
tyramine (K = 5 x 1Q -4) and so concluded that it was 
unlikely to be of physiological importance in the 
clearance of adrenaline. Bacq (1936b)also pointed 
out that the action of amine -oxidase in vitro takes 
hours, whilst adrenaline in vivo is inactivated in a 
few minutes. 
Rate of action of henol oxidase cytochrome oxidase 
and ep roxidase. 
Blaschko and. Echlossmanr_ (1940) found with 
polyphenol oxidase and adrenaline(1:l000)that 70 
p.c. was inactivated in 9 mins. at 19 °C.; with 
cytochrome oxidase 75 p.c. inactivation occurred in 
51 mins. at 19°C. and with peroxide se at a slower 
rate than with cytochrome oxidase. The rate of 
t 
action of polyphenol oxidase approximates /the 
rate of adrenaline inactivation in vivo. 
B. / 
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B. Adrenaline Clearance in vivo. 
Adrenaline disappears from the blood stream 
very rapidly. Elliott (1905) found that large 
doses of adrenaline (1 mgm.) injected intravenously 
into the cat disappeared from the blood in three 
minutes. Similar results were obtained by De Vos 
and Kochmann (1905) who injected adrenaline into 
rabbits and found that the drug disappeared from the 
blood in about 10 mins. It has also been shown 
by several authors that the disappearance of 
adrenaline from the blood stream parallels the 
effect on the blood pressure (Elliott, 1905; Jackson 
1909; Trendelenburg, 1916; B acq, 19360; the same 
is true of many other tissues, such as urethra, 
uterus, bladder, eye, ilr colic sphincter (Elliott, 
1905). 
Many workers have shown that intraarterial 
injections of adrenaline are less effective than the 
intravenous. Carnot and Josserand (1902) found that 
moderate doses of adrenaline, injected into the 
carotid or femoral artery or large doses (0.0£4 mgm. 
per kg.) given into the mesenteric artery, produced no 
effect on the general circulation of dogs. Clark 
and itaven.tos (1939) found that the ratio between 
the/ 
the equisctive doses of adrenaline administered into 
the vein and into the artery was 1 :6. 
These results can partly be explained by 
distribution of the drug in the plasma volume, 
assumed to be 5 p.c. of the body weight. Intra- 
venous injection only mixes with half the blood 
before it circulates round the body. Hence there is 
immediate dilution in less than 5 p.c. body weight. 
Intra- arterial injections, on the other hand, 
diffuse in the body tissues and mix with the whole 
blood after first circulation. Adrenaline is 
quickly distributed in 25 p.c. body weight (tissue 
fluid volume), hence rapid fall to one fifth of the 
original concentration is to be expected. 
The role of various bod tissues in the inactivation 
of a rena ne in VIVO. 
Elliott (1905) concluded that adrenaline 
destruction occurs in all the tissues stimulated by 
the drug. Many workers, though agreeing with the 
statement of Elliott, emphasize the importance of the 
liver in the inactivation of adrenaline in the body. 
This view is strengthened by the experiments of 
Beyer (1941) and Beyer and Vernon who found that 
some/ 
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some sympathomimetic amines were excreted unchanged 
when the liver in animals was made inactive by 
certain poisons. Philpot and Cantoni (1941) 
found that in vitro methylene blue inhibited amine - 
oxidase obtained from the liver and had no effect 
on other oxidases. They compared the equivalent 
doses of adrenaline given into the jugular and 
splenic vein before and after the intravenous in- 
jection of methylene blue, and found that the ratio 
of the equivalent jugular and splenic doses was 
changed from 1 :6 to 1:2. after the administration of 
methylene blue. These results suggest that the 
reduction in the rate of inactivation of adrenaline 
after the administration of methylene blue is 
probably due to inhibition of amine -oxidase in the 
liver. 
Excretion of adrenaline. 
Earlier authors (Oliver and Schafer, 1895; 
the 
Jackson, 1909) found that the exclusion of /kidneys 
from the general circulation resulted in no pro- 
longation of the duration of action of sdrenaline,and concluded 
that the drug was not excreted unchanged. 
Weinstein and Nanning (1937) reported that a proto- 
catec1 is acid -like substance was excreted into the 
urine/ 
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urine after injection of adrenaline in the rabbit, 
and suggested that this wa:i the oxidation product 
of adrenaline by amine -oxidase. Richter (1940) 
however, considers this to be an artifact produced 
by the action of alkalies on adrenaline. Richter 
(1940) and Richter and Ìvackintosh (1941) showed ' 
that in man and rabbit, adrenaline administered 
orally was excreted in the urine in conjugation 
with sulphates. They recovered 50 to 70 p.c. of 
the administered adrenaline from the urine, and 
concluded that conjugation was the main physiological 
process by which the drug was inactivated in the 
body. 
-25- 
IV. CUiuiULhTION AND CLEARANCE OF ADRENALINE. 
The nature of the clearance of labile drugs such 
as adrenaline can be judged from the cumulation 
effect produced by continuous infusion. The two 
known forms of clearance are: 
(a) Clearance of a quantity per minute which. is 
constant and does not change when the amount present 
in the body is increased. In this case if the 
quantity cleared per minute is x /kg./min., then 
continuous infusion with this rate will produce 
practically no effect, and infusion at a greater rate 
will result in a steadily increasing response. 
(b) Clearance which increases when the amount of 
drug in the body increases. In this form of clear- 
ance, cumulation will occur until the amount intro- 
duced per minute equals the amount cleared per 
minute. Equilibrium or plateau response is thus 
produced, and when this occurs the rate of clearance 
can easily be calculated, since it equals the amount 
introduced per minute divided by the amount 
cumulated. If a clearance process such as has been 
described occurs, then a series of different rates 
of infusion will result in plateaus of cumulation 
at a series of different levels. Lost of the 
drugs/ 
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drugs, including those whose clearance depends 
upon enzyme action, are cleared in this manner. 
The author (Ansari, 1942) found that the 
clearance of adrenaline was such that the amount 
cleared per minute varied as (amount cumulated) 
0.66 
Since the publication of this paper a better method 
for mathematical representation of the result has 
been devised which differs in some respects from 
the previous one. The calculations given below 
are done by this new method. 
EXPERIMENTAL. 
Methods. 
Cats were used in all the experiments. With 
some exceptions in which chloralose (0.1 kg. intra- 
venously) was given, all the experiments were made 
on cats whose brain and spinal cord were destroyed 
under ether anaesthesia. The details are as 
follows: After weighing,the animal was anaesthetised 
with ether and placed on an operation table heated by 
means of electric bulbs underneath. The trachea 
was exposed by a median incision in the neck and a 
cannula inserted. The anaesthesia was then con- 
tinued through. the tracheal cannula. 
Destruction of the C.N.L. 
with 
The head of the cat was firmly held lad the left 
hand and a vertical incision extending from the 
vertex to the root of the nose was made in the scalp. 
At the root of the nose the above incision was joined 
by a second incision extending to the right ear. A 
triangular flap of the scalp thus formed was turned 
up and the periosteum over the exposed bone was 
scraped off. By means of a trephine an opening 
was made in the skull. In order to avoid the venous 
sinus / 
sinus (sagittal sinus) the site chosen for 
trephining was about half an inch to the right of 
median line. A sharp narrow scalpel was passed 
the 
through the opening in the skull andAmedulla 
oblongata was cut across at the level of the 
Foramen Pagnum. The brain was then destroyed 
by means of a curved blunt dissector and the 
destruction of the spinal cord was completed by 
passing into the spinal canal through the Foramen 
Magnum e a flexible smooth tipped copper wire 
about two feet long. Immediately after the 
the 
destruction of /.brain and spinal cord the opening 
in the skull was plugged, anaesthesia was discon- 
tinued and artificial respiration started. 
Ligation and removal of suprarenal glands. 
The suprarenal glands were excluded from the 
general circulation either by their complete removal 
or by simple ligation in the manner described below. 
The abdomen was opened by a median incision and 
the glands were exposed by incising the overlying 
peritoneum. Two ligatures one on either side of 
the gland were tied and to ensure a complete 
exclusion a third was tied round the body of the 
gland. The glands in some experiments were removed 
after¡ 
_2 
after such ligation. The ligation as well as the 
removal of the right suprarenal gland required more 
care on account of its being in close relation with 
the inferior vena cava and the liver. After the 
ligation was completed some warm saline was put 
in the peritoneal cavity and the abdomen was closed 
by means of artery forceps. 
Removal of the left superior cervical ganglion 
and section of the ' vazi. 
The incision in the neck made for tracheotomy 
was enlarged and the left superior cervical ganglion 
was isolated and removed. Both the vagi were then 
cut in the middle of the neck. 
Blood pressure record: B.P. was recorded from the 
right femoral artery by means of a mercury manometer. 
The manometer system contained half saturated sodium 
sulphate solution. In addition to this, a small 
quantity of sodium oxalate was put in the arterial 
cannula as an anticoagulant. 
Contraction of the left nictitating membrane. The 
head of the cat was rigidly fixed in a clamp and the 
outer corner of the eyelid was incised to allow the 
free movements of the n.m. A fine thread was then 
tied in the middle of the n.m. and the contractions 
were recorded by attaching the free end of the 
thread / 
thread to an isotonic lever with a writing point 
on a revolving kymograph. 
Preparation of adrenaline solution. Adrenaline 
hydrochloride solution 1:1000, prepared by Parke, 
Davis and Co.,was used in all the experiments. This 
was diluted with distilled water just before the 










These dilutions correspond respectively to 300,100, 
30, 10, 3, 1, 0.3 and 0.1 micrograms of adrenaline 
in 1 c.c. of the solutions. 
Fresh diluted adrenaline solutions were made if 
required after two hours of their preparation. 
Administration of adrenaline: The solutions of 
adrenaline were given into the femoral vein as 
single injections and continuous infusions. In the 
case of single injections 1 c.c. of the solution of 
known strength was taken into a 1 c.c. glass 
syringe fitted with a fine needle and injected into 
the/ 
the femoral vein through the rubber tubing connecting 
the venous cannula to a burette containing warm. 
saline. In addition another 2 c.c. of warm saline 
from the burette were run in, making the total 
volume of the fluid injected to 3 c.c. 
Continuous infusions of adrenaline. 
The whole success of the experiments with. 
continuous infusions of adrenaline depends upon the 
maintenance of the uniform rate of inflow of the 
drug. This was accomplished by means of an apparatus 
shown in Fig. 1. 
This consisted of a 10 c.c. record syringe, a 
wheel having a circular hole in the centre and a 
square rod. The wheel was placed between two 
supporting pillars, and was rotated by means of a 
belting from an electric motor. The wheel had 
screw threads in its central hole corresponding to 
the threads on the square rod. The square rod was 
passed through the circular hole of the wheel and 
also through the square holes of the supporting 
pillars. When the wheel was rotated it :mnade the 
square rod to rotate also, but the square holes in 
the supporting pillars prevented this and a forward 
movement of the rod wee resulted. The distance through 
which/ 
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which the rod was moved with each complete rotation 
of the wheel was er.ual to the distance between the 
threads. 
A 10 c.c. syringe filled with adrenaline 
solution of known concentration was fixed in 
clamps; its nozzle was connected by means of a 
rubber tubing to the cannula in the femoral vein, 
and the plunger was brought into contact with the 
square rod which pushed it forward a uniform 
rate. The rate of the infusion can be changed 
either by altering the speed of the motor or by 
changing the concentration of t'.e drug in the 
syringe. The latter method was adopted in all 
the experiments when a change in the continuous 
dose was desired. 
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infusion. Cumulation with continuous adrenaline 
Oliver and SchRfer (1895) found that intra- 
venous infusions of suprarenal extracts produced 
a rise in the blood pressure 1 vol which. maintained 
its level as long as the infusion was continued. 
Kretschmer (1907) found that different rates of 
infusions of adrenaline, in the cat, produced 
plateau response of different heights. Infusions 
of larger doses than those which produced the 
maximum rise of blood pressure, however, did not 
increase the height of the plateau but prolonged 
the time of recovery after the infusion was stopped 
Dragstedt et al (1928) administered adrenaline 
with uniform rates of 0,2 to 0.4 µg /kg. /min. and 
found that it produced a sustained rise of the 
blood pressure in normal unanaesthetized dogs. 
Similarly many other authors have shown that 
infusions of adrenaline at constant rates will 
maintain a response at constant plateau for a long 
time (Trendelenburg, 1924; Rosenblueth, 1932; 
Prohaska et al (1937) . 
In figs. (2a, 2b, 2c and 2d) and (3a and 3b) 
are shown the tracings of the responses of the 
nictitating membrane and blood pressure. to various 
doses/ 
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doses of quick injections and continuous infusions 
of adrenaline in two experiments. The dose of 
continuous infusions in these experiments ranged 
from 0.46to 4.66 4g /kg. /min. These infusions 
produced plateaus of :different heights according 
to the dose administered; the height of plateau 
being below the maximum response of the nictitating 
membrane or blood pressure. Figs.4a á; 4b show the 
effects of quick injections and of a large dose of 
continuous infusion (6.02 li.g /kg. /min.) on the 
nictitating membrane in another experiment. The 
height of plateau response in this case also was 
below the maximum response of the tissue as can 
be seen from the amplitude of the response to 
quick adrenaline dose of 86.8 kg/kg. (Fig. 4a) . 
A stilly of the response to continuous infusion 
of adrenaline shows that the plateau is attained 
in from 2 -5 minutes and can be maintained for a long 
time. The response of the blood pressure to continuous 
infusions of adrenaline was less satisfactory as 
the plateau was not maintained, but declined soon 
after reaching the maximum; this was more marked 
with large doses of continuous infusion (Fig. 7). 
The nictitating membrane, on the other hand, gave 
a/ 
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a steady plateau response (with large as wellas 
with small continuous dose) which was maintained 
as long as the infusion was continued. soon after 
the discontinuation of the infusion the nictitating 
membrane and blood pressure began to recover and 
reached their original level in periods depending 
upon the rates of infusion and the amount of 
cumulation. 
Estimation of the cumulated amount of adrenaline. 
In order to estimate the amount of adrenaline 
cumulated when a plateau response was attained by 
continuous infusion, the cats were first standardized 
by a series of quick injections and the continuous 
infusions interspersed. The results of 12 experi- 
ments, summarized in Tables 1 and 2, are shown in 
Figs. 5 and 6.Thecurves in Fig. 5 show the relation 
between the logarithms of quick and continuous 
doses of adrenaline and the heights of responses of 
the nictitating membrane and blood pressure from 
the collective results of 6 experiments given 
in Table 1. Fig. 6 shows similar results obtained. 
in 4 sensitive and 2 insensitive cats with the 
nictitating membrane response. 
The /. 
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The sensitivity as is seen from Fig. 6 varied with- 
a fivefold range. The dosage response curves 
as 
follow a hyperbolapkfound by many authors (Rosen. - 
blueth, 1932; Becq, 1936; Clark and Raventos, 
1939) . The curves in Figs. 5 end 6 are drawn 
to the formula ,that expresses ti..e reversible 
unimolecular reaction: 
100 -y 
where x = concentration, y = percentage of response 
and 100 = the maximum response. The values of the 
maximum response and k for these curves are given 
at the foot of each figure. The calculated curves 
where they deviate from the observed curves are 
shown by dotted lines. In all cases continuous 
infusion of adrenaline resulted in a plateau being 
attained. The graphs show that all the responses 
to continuous infusions were below the maximum 
response; hence the plateau was not due to the 
tissue having contracted to the maximum extent. 
in cases where large doses of continuous 
adrenaline were a .dministered,this point was Ion- 
a 
firmed by giving1\quick injection of the drug in 
addition to the continuous flow, and this produced 
an/ 
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an extra response in all cases. In Fig. 7 is 
shown the response of the nictitating membrane to a 
continuous dose of 10.1 Ea.g /kg. /min., at point ° °p°' 
ans additional quick injection of 12.6 4g/kg. was 
given, which resulted in an extra contraction of 
the tissue. 
The fact that a plateau effect was produced 
with large doses (10 µg /kg. /min.) indicates that 
the rate cf clearance was increasing with the 
amounts present as the result of these rates of 
injection. Hence the conclusion of Clark and 
Raventos (1939$) that enzyme saturation occurs with 
doses of over 3 11g/kg. is probably incorrect. 
Source of error in the method of estimation of 
cumulation. 
The cumulation with continuous infusion when 
a plateau is attained has been assumed to be equal 
to the amount of adrenaline which produces the same 
effect when given as quick injection. Thia 
This assumption will be reasonable If there is no 
large difference in the distribution in the two 
cases. 
The plasma volume of a cat is about '5 per cent. 




are about 25 per cent.Obody weight. A quick 
injection of adrenaline thus will reach the 
susceptible tissue before being mixed up with whole 
blood. Therefore a dose of 1 pg /kg. when injected 
intravenously will for some time act on the 
susceptible tissue irlmuch higher concentration 
(20 µg /kg.). In the case of continuous infusion, 
however, there is enough a time for the equal 
distribution in the blood and tissue fluid; so a 
dose of 1 µg /kg. is unlikely to produce a concen- 
tration of more than 4 µg /kg. 
In order to determine how far this source of 
error has affected the results, a series of doses 
of adrenaline were given alternately as quickly 
as possible and spread over more than a minute. 
The responses of the blood pressure were equal 
under the two conditions, whilst the responses of 
the nictitating membrane were about 25 per cent. 
less with the slow injection (Table 3) . These 
results indicate that the ratio of the ecuie.ctive 
doses with slow and quick injection is certainly 
less than 2:1 and may be equal to 1 :1. 
The responses of the nictitating membrane 
and blood pressure to quick injection of adrenaline 
take from 0.5 to 3 minutes to reach the peak, whilst 
the / 
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the response to continuous infusion attains a 
plateau in about 3 -5 minutes. Adrenaline there- 
fore does not act very rapidly but quickly atteins a 
plateau with continuous infusion. The above 
facts indicate that the differences in distribution 
with the two forms of injections of adrenaline 
(quick and continuous) are not very important; 
hence the assumption that the height of plateau 
produced by continuous infusion indicates the 
concentration of adrenaline, equal to the amount 
which produces the same effect given as quick 
injection seems to be reasonable. 
The blood pressure responses were not as 
satisfactory for measurement as were those of the 
nictitating membrane, but in general showed the 
same relation between dosage and height of 
plateau response. The ratio quick dose (µg /kg.)/ 
continuous dose (µg /kg./min.) was nearly unity 
with doses near the threshold and rose to about 
5 with large doses. 
Relation between continuous and quick dosage. 
Figs. 8 and 9 show the averages of the results 
of 27 and 16 experiments given in Tables 4 and 5. 
The relation between these two forms of dosage is 
that/ 
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that continuous dose varies as (quick dose)2 /3. 
The amount introduced perlinute when the plateau 
is attained equals the amount removed per minute, 
the quick dose indicates the amount cumulated. 
Hence the figures show the relation between the 
concentration of the drug present and the amount 
removed per minute. The relation found indicates 
therefore a clearance by a process in which the 
amount of substrate changed per minute (i.e. rate 
of introduction b ) varies as (substrate concentration)2 /3 
or b = k (x)2/3 , where x is the concen- 
of adrenaline. 
dx = -k.x2/3 
dt 
x-2/3 dx = - kdt 
Integrating we get 
x1/3 = xo 1/3 -4 t 
where xo = concentration at zero time. 
Dosage duration relation 
If the above equation expresses t,e clearance 
then the relation between the concentration x 
0 
at 
zero time and the duration of action (t) measured 
till x falls to a threshold value of x, will be as 
follows: 
This/ 
xo1 /3 = x11/3 + 3 t 
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This implies that t shows a linear relation to 
x01 /3. This can be seen from Figs. 10 and 11, 
which give the averages of the results of 8 experi- 
ments (Tables 6 and r). 
Analysis of the response to cumulative dosage. 
In Fig. 12 is shown the response of the 
nictitating membrane to a continuous dose of 3.4 
pg /kg. /min. adrenaline administered for 10 mins. 
The scale on the right ordinate shows the adrenaline 
the 
equivalent (pg/kg.) calculated fromAdo sa g e-res p onse 
curve. The plateau height indicates cumulation 
of 14 pg /kg. Curve A in the figure shows the 
response which should occur if there were no 
clearance. Curve B shows the cumulation of adren- 
aline calculated by means of the following formula 
derived from the relation found between quick end 
continuous dosage described before. 
dx = b - kx2 /3 
dt 
or 1 dx = dt 
b - kx2 /3 
where x is the concentration of adrenaline and (b) 
the rate of introduction of adrenaline. 
The value of k can be found from the graph 
(F 6.131 which shows the relation between x1 /3 
and/ 
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and time (t) and equals 0.39. The times (t) 
for different values of concentration (x) were 
calculated by integrating the expression 
Jr dx 
b - kx2/3 graphically. According to this 
calculation the concentration rises to 17 µg /kg. 
in 10 minutes. 
Curve C, which shows the course of clearance 
when the initial concentration is 1'7 vg /k.g., was 
calculated by means of the formula: 
x1/3 = xol /3 k t 




k (from graph 13) = 0.39 
Hence t = 2.57 x1J3 
0.13 
By putting the values of x1/3 the time for these 
concentrations can easily be calculated.from the 
above formula. 
Fig. 14 shows the analysis of the response of 
the nictitating membrane to a large dose of 
adrenaline (6.02 µg / /kg. /min.) The method of 
calculation was the same as that employed for the 
analysis of Fig. 12. Fig. 15 shows the relation 
between dose1 /3 and the duration of action (t) 
found in the experiment, and from which tre values of 
k/ 
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k in the equation for cumulation and clearance 
were found. 
It is seen in these figures that the calculated 
cumulation and recovery curves are in approximate 
agreement both as regards the concentration attained 
in given time of infusion and as regards the 
duration of the clearance. The differences 
between the observed and theoretical curves may 
be perhaps due to the mechanical properties of the 
plain muscle of the nictitating membrane. 
Additive effects. 
The validity of the method used depends upon 
the assumption that the production of a plateau 
response of a certain height represents that a 
certain concentration of adrenaline is present in 
the blood stream. 
This assumption was tested by giving continuous 
infusions until plateaus were attained and then 
adding a quick injection of adrenaline. Figs. 16a, 
16b and 16c show the responses of the blood pressure 
and nictitating membrane to quick adrenaline injection 
and also the effect of a quick dose of 11.5 p.g /kg. 
adrenaline administered during continuous infusions 
of the drug. It can be seen that the quick dose of 
11.5/ 
-44- 
11.5 4g /kg. when given during the continuous 
infusion of 0.53 or 1.79 µg /kg. /min. produced 
about the saine height of response as when given 
alone. But with the continuous dose of 5.3 µg /kg./ 
min. the response to quick injection was decreased. 
The results with the nictitating membrane from this 
and another similar experiment are shown in Figs. 
17 and 18 respectively. The continuous line and 
dots represent the relation between dosage and 
height of response of the nictitating membrane to 
quick injections of adrenaline. The crosses show 
the heights of plateau produced by continuous 
infusions at the rates indicated by the abscissae. 
The dotted lines, circles and numbers indicate 
the extra response produced by quick injections of 
adrenaline given during the continuous infusions. 
The adrenaline equivalents to the crosses and 
circles can be read off from the dosage -response 
curve. Table 8 shows how the effect of the 
additional quick adrenaline injection was calculated 
from the results given in Fig. 18. 
with low doses of adrenaline the difference 
between the adrenaline equivalents of the responses 
is similar to the additional quick dose of adrenaline 
that was given, but with larger doses the calculated 
dose/ 
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dose was 3 to 5 times as greet as the dose given 
Table 9 shows the figures calculated in a similar 
manner from 6 experiments with continuous doses greater 
than 5 µg /kg. /min. which produce a response of one - 
quarter the maximum or less, the figures calculated 
from the response to additional injection are 
approximately correct, but when large doses were 
given with continuous injection the added 
response was much greater than was be expected. 
Blood pressure responses also were measured 
and these gave similar results with low rates of 
continuous infusion, but with higher rates the 
plateau was not maintained at a constant level, 
and hence quantitative estimates of additional 
response could not be made. 
Interpretation. 
The most probable reason for the excessive 
responses produced by quick doses after large 
continuous doses is that the latter saturate 
the tissue fluid and cells with adrenaline and 
hence check the diffusion out of the plasma of 
quick doses. 
In calculation of the effect of additional 
quick/ 
-46- 
quick doses of adrenaline described above, the 
the 
fact that dosage- response curve follows a hyperbola 
will lead to quite different conclusions unless 
caution is exercised. For example the relation 
between the rate of continuous infusion and the 
amplitude of the nictitating membrane response to a 
constant dose of added quick injection found from 
Fig. 18 are as. follows: 
Continuous injection 
µg /kg. /min. 0 3.4 5.0 6.8 10 
Height of response 




curve 10 10 31 42 50 
This shows that as the continuous dose increases, 
the amplitude of the nictitating membrane response 
to a constant quick dose is decreased, but if the 
adrenaline equivalents of these responses be 
measured from dosage -response curve, it is found 
that this figure rises as the rate of continuous 
injection is increased. 
It is evident from these results that the 
measurement of the amplitude of response without 
considering the dosage -response relation, would 
lead/ 
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lead to the wrong conclusion that continuous 
adrenaline infusion inhibited the action of quick 
injections of the drug and this might be produced 
as a proof of the "potential action" of adrenaline. 
In fact the reverse is the truth and continuous 
administration increases the effects produced 
by quick injection. This provides a simple 
example of the errors that can occur in calculating 
synergisms or antagonisms of drug action. 
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V. THE INFLUENCE JF ENZYME INHIBITORS JN THE 
ACTION AND CLEARANCE OF ADRENALINE. 
Enzymes differ in their behaviour towards 
different enzyme poisons; for example amine -oxidase 
is inhibited by narcotics, cocaine and ephedrine, 
but not by ascorbic acid or cyanide.. rhenol 
oxidase and cytochrome oxidase, on the other hand, 
are inhibited by cyanide ana ascorbic acid but not 
by cocaine or ephedrine. 
The nature of the enzyme system concerned 
ir: the inactivation of adrenaline in the body 
therefore can be studied by testing the influence 
of certain enzyme inhibitors on the action and rate 
of clearance of the urúg in vivo. 
Experiments here described were made in 
order to study the influence of cocaine, pyrogallol 
and ascorbic acid on adrenaline clearance in the cat 
and in the light of this probable mechanisms of 
their action discussed. 
Methods. In general the methods used were 
the sanie as have been described before. The brain 
and/ 
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and spinal cord of the cat were destroyed under 
ether anaesthesia. The suprarenal glands were 
excluded from the general circulation by ligation, 
the vagi were cut and the left superior cervical 
ganglion was removed as the left nictitating membrane 
was used in all the experiments. The blood 
pressure was taken from the femoral artery. The 
response of the nictitating membrane was recorded 
by an isotonic lever. All the drugs were injected 
into the femoral vein. 
The response of the nictitating membrane 
to continuous infusion of adrenaline gave more 
the 
satisfactory results than that of /blood pressure, 
as with the latter the plateau effect was not 
maintained for any length of time but declined as 
the infusion was continued. 
(1) The influence of pyroallol. 
ryrogallol is a strong reducing 
agent. It prevents the oxidation of adrenaline 
in vitro. Bacq (1936b,c) showed that various 
reducing agents, and pyrogallol in particular, 
greatly increased the duration of action of 
adrenaline. He concluded that they did not prolong 
the/ 
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the time during which adrenaline remained in the 
blood stream, but decreased its rate of destruction 
in the tissues. He also found that pyrogallol 
produced a tenfold increase in the amplitude of 
the response of the nictitating membrane to 
adrenaline. Clark and Raventos (1939) found that 
the rate of clearance of adrenaline was reduced 
to one fourth after the administration of pyrogallol. 
They did not observe any marked increase in the 
amplitude of the response of the nictitating 
membrane or blood pressure. 
, EXPERIMENTAL. 
In the present experiments the response of 
the nictitating membrane and blood pressure both to 
quick injections and continuous infusions of 
adrenaline were first determined. pyrogallol in 
doses of about 40 mg /kg. was dissolved in distilled 
water and slowly injected into the femoral vein. 
After an interval of about 5 minutes, the quick and 
continuous adrenaline injections were then repeated; 
the doses of the drug used were the same as before 
the administration of pyrogallol. 
In Fig. 19 the logarithm of the dose of 
adrenaline/ 
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adrenaline given both quickly and continuously 
is plotted against the height of the response of 
the nictitating membrane from the collective results 
of four experiments given in Table 10. 
The curves k and b in the figure represent 
the effect of quick adrenaline injections before 
and after pyrogallol respectively. It can be 
seen that no marked increase in the response of the 
nictitating membrane to threshold doses of 
adrenaline occurs after pyrogallol. ';ith large 
doses, hors ever, there was an increase in the 
amplitude after pyrogallol, the doses for equi- 
valent effects being decreased threefold. 
The relation between continuous dose and 
the height of plateau response before and after 
pyrogallol are shown by lines Al and B1 in Fig. 19. 
The equivalent to any plateau height, i.e. the 
amount that has cumulated, can be read off from 
curves A and b. In Fig. 20 the continuous dose 
of adrenaline is plotted against the equivalent 
quick dose, both before and after pyrogallol, from 
the averages of the results of 8 experiments. 
given in Table ll. It can be seen that pyrogallol 
reduced the rate of inactivation of adrenaline,so 
/ \ that/ / n\ 
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that the amount of equivalent quick dose to a 
certain continuous dose was higher than before its 
administration, but it did not change the relation 
between these two forms of dosage, i.e. "continuous 
dose varies as (quick dose)2/ 
Dosage duration relation before and after pyrogallol. 
In Fig. 21 the cube root of the dose of 
adrenaline is plotted against the duration of action 
of the drug on the nictitating membrane from the 
averages of the results of 7 experiments (Table 12) . 
Line B in the graph shows the relation found before 
and A after the administration of pyrogallol. The 
difference between the rates of clearance of 
adrenaline found from the slope of these curves 
indicates that the clearance of adrenaline is 
reduced to about 40 per cent. 
Response to continuous infusion of adrenaline after 
pyrogallol. 
Fig. 22 represents the response of the 
nictitating membrane to a continuous dose of 1.09 
µg /kg. /min. given for 11.5 mina. after the 
administration of 40 mg /kg. of pyrogallol. The 
right ordinate in the figure shows the adrenaline 
equivalent ( hg., /kg.) for various heights of 
response/ 
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response calculated from dosage response curve. 
The height of the plateau indicates cumulation of 
5.62 µ g /kg. adrenaline. 
Curves A and b in the figure show the 
course of cumulation and clearance calculated 
by means of the formulae: 
1 
b - kx 213 
dx = dt for cumulation 
x 3 = xó l3 - 3 t for clearance 
derived from the relation between quick and 
2 
continuous dosage. (b = k(x0 where b = the 
continuous dose and x the concentration). 
The value of k/3 being found from Fig. 23 which 
shows the relation between the(dose0 and the 
duration of action. The calculated cumulation 
and clearance are in approximation with observed 
course of cumulation and clearance. 
In Fig. 24 are shown the responses of the 
nictitating membrane to continuous dose of 1.48 µg/ 
kg. /min. adrenaline infused (A) before and (A1) 
after pyrogallol.administration. The scales on 
the right ordinate show the adrenaline equivalents 
( v g /kg..) (1) before and (2) after pyrogallol, and 
are/ 
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are calculated from the dosage response curves. 
Curves B and Bl represent the cumulation and 
C and Ci the clearance before and after pyrogallol, 
calculated in the same manner as shown for Fig.23. 
The values of 
3 
was found from the curves given 
in Fig. 25 which shows the relation between 
(dose)I¡3 and duration of action before and after 
pyrogallol administration. 
Comparison of the responses of the nicti- 
tating membrane in Fig. 24 shows that the increase 
in the height of plateau produced by pyrogallol 
is due to a higher degree of cumulation of 
adrenaline. The greater amount of adrenaline 
cumulation after pyrogallol may be due to a 
diminution in the rate of its clearance. 
(2) The Influence of Cocaine. 
Chemistry. Cocaine is obtained from the leaves of 
erythroxylon coca. It is a white crystalline substance 
not easily soluble in water but soluble in organic 
solvents and destroyed by prolonged boiling. It is a 
strong base and forms salts with acids, the hydro- 
chloride being most frequently used in medicine. 
Cocaine is double ester of ecgonine and benzoic acid 
and methyl alcohol. Its formula has been prove0 by 
the synthesis of cocaine from these constituents. 
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It has long been known that cocaine . 
potentiates the action of adrenaline in vive as 
well as in vitro. Frchli ch and Loewi (1910) 
found that in the intact animal cocaine augmented 
the action of adrenaline on blood pressure, pupil, 
and urinary bladder. Later many suthors showed 
that the action of adrenaline on the isolated 
tissues end the tissues ;n situ was potentiated 
by cocaine.Thienes_ and Hackett (1928) reported 
augmentation of adrenaline effect on the isolated 
uterus of the virgin rabbit. Tripod (1940) 
end Jeng (1940) found similar aug er_tat'_cr_ of 
adrenaline action on the isolated frog's and cat's 
heart, rabbit's ear, virgin cat's uterus end 
intestine in the presence of low concentrations of 
cocaine. Tatum (1920) found that in dogs and 
rabbits the response of the blood pressure to 
splanct'nic stimulation was increased after intra- 
venous administration of small doses of cocaine. 
Tainter (1929, 1930, 1931) and Wirt and 
Tainter (1932) found that the blood pressure 
response to adrenaline was doubled after 
subcutaneous injection of 15 -30 mg. /kg. of 
cocaine/ 
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cocaine hydrochloride. hacq and Fredricq (1935) 
showed that the response of the nictitating 
membrane to adrenaline was increased 4t, sixfold 
after cocaine administration. Luduena (1940) 
found with some sympathomimetic amines (epinine 
and sympatbl) that their effect on the dog's 
retractor penis muscle and blood pressure was 
potentiated by intravenous cocaine in doses of 
0.5 to 4.5 mg. /kg. 
iosenblueth (1931) observed augmentation 
of adrenaline effect in the nonpregnant uterus 
and on the stomach of the cat with cocaine. He also 
(1932) suggested that cocaine produced an increase 
in the duration of action of adrenaline by lowering 
its threshold dose. Labate (1941) found that 
the inhibitory effect of adrenaline on the uterus of the 
nonpregnant cat lasted two or three times longer,when 
0.3 mg. cocaine was given irrLrí edia.tely after the in- 
jection of adrenaline. Clark and Raventos (1939k) 
concluded from their experiments on the action of 
adrenaline and cocaine on the blood pressure and 
nictitating membrane of cats, that the increase 
in the duration of action after cocaine was due to 
the change in the threshold doses. Tainter(1930) 
concluded that the potentiating action of cocaine 
was/ 
was not due to any interference with the oxidation . 
processes in the tissues. 
Lawrence et aí.(1942) calculated the rate 
of inactivation of adrenaline in Lockets solution 
perfused through the hind limbs of the cat. They 
found that the presence of cocaine in the perfusion 
fluid in concentrations of 1:500,000 to 1:150,000 
caused a 40 per cent. decrease in the rate of 
inactivation of adrenaline. 
The influence of cocaine and other local 
anaesthetics on the inactivation of adrenaline by 
enzymes in vitro has recently been studied by the 
following investigators: rhilpot (1940) showed 
that the rate of oxidation of adrenaline in vitro 
by amine -oxidase obtained from the guinea pig's 
liver was reduced 60 to 100 per cent. by cocaine, 
percaine and stovaine. This author has also 
shown that cytochrome oxidase is also inhibited 
by cocaine. Bayer and Wense (1938) and Wense 
(1939) showed that cocaine slowed the rate of 
oxidation of adrenaline by tyrosinase and acetalde- 
hyde. Bain et al. (1937 ), on. the other hand ,could 
not find any change in the rate of destruction of 
adrenaline/ 
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adrenaline incubated with liver slices after the 
addition of cocaine. 
EXPERIMENTAL. 
Cocaine hydrochloride dissolved in distilled 
water was injected intravenously in doses of 1.5 
to 10 mg. /kg. In the majority of animals this 
alone gave rise to a response in the nictitating 
membrane and blood pressure. Trie dose of cocaine 
above 3 mg. /kg. always produced a response. The 
response of the nictitating membrane to cocaine 
developed slowly, reached a peak in about '7 mins. 
end took a long time for recovery. An example of 
such a response is shown in Fig. 26. 
Intravenous doses of cocaine from 1.5 to 
2 mg. /kg. increased the sensitivity of the 
nictitating membrane to small as well as to large 
doses of adrenaline (0.03 to 50 Flg /kg.)(Table 13). 
The doses of cocaine above 3 mg. /kg. were generally 
found to inhibit the action of large doses of 
adrenaline (above 15 pg /kg.) . Fig. 27 shows 
the effect of cocaine on the responses of the 
nictitating membrane to various doses of adrenaline 
in two experiments. Curves B and B1 show the 
relation/ 
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relation between the amplitude of the response end 
the dose of adrenaline before and after the 
administration of 3.9 mg /kg. of cocaine respectively. 
It can be seen that responses of the nictitating 
membrane to adrenaline doses above 15 µg /kg. were 
diminished. The antagonising effect of cocaine 
was more marked after a larger dose and can be 
seen from the results of another experiment shown 
by curves A and Al in the figure. 
The effects of s sitizin g doses of cocaine on the 
action and clearance 6T-adrenaline. 
s for pyrogallol , the cats were first 
standarized to single injections of adrenaline and 
this was followed by continuous infusion of the 
drug. Then cocaine hydrochloride dissolved in 
distilled water was injected through the cannula 
in the femoral vein. 1J -15 minutes were then 
allowed to elapse, for the cocaine to be distributed 
throughout the body. Single injections and contin- 
uous infusions of adrenaline were then repeated in 
the same doses as before the administration of 
cocaine. 
Fig. 28 (Table 14) gives relations between 
the/ 
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the amplitude of the response of the nictitating 
membrane to single injections and continuous 
infusions before and after cocaine administration. 
These results show that cocaine produces a marked 
lowering of the threshold dose of adrenaline. Tne 
r..in.imum effective dose of adrenaline was reduced 
from 0.3 to 0.03 vg/kg. after cocaine injection. 
It can also be seen that the proportional increase 
in the sensitivity to adrenaline was larger when 
tested with doses of adrenaline below 1 µg /kg. 
than when tested with larger doses. The effect of 
cocaine on the blood pressure responses to 
adrenaline both when given as quick injections or 
continuous infusion gave similar results to that 
of n.m. (Fig. 29 and Table 15). 
Relation between. quick and continuous dosage after 
Föcaine. 
The plateau effect produced by continuous 
infusion of adrenaline after cocaine administration 
was limited to the rates of about 3 Lg /kg. /min. 
corresponding to the cumulation of about 30 Ilg /kg. 
Be;Jond this dose no definite plateau response was 
obtained. The amount of concentration reached as a 
result of continuous infusion was estimated from 
the/ 
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the equivalent quick dose as before. The relation 
between these two forms of dosage after cocaine 
administration is shown in t ig. 30 by line A from 
the averages of 5 experiments given in Table 16. 
that 
The graph shows,' the relation found ( continuous 
dose varies as (quick dose 1 does not change after 
the administration of cocaine. The above relation 
indicates a form of clearan.ce,the course of which 
r 
1 allows according to the formula x3 = x ©3 -kt 
I" 
In such a case the relation between (dose)3 and 
the duration of action of adrenaline should be 
linear, as is shown by the graph in Fis. 31 
(Table 17). 
The rate of clearance of adrenaline before 
and after trie administration of cocaine can be 
calculated from the slope of the curves B and A 
respectively. Comparison of these rates shows 
that cocaine has reduced the rate of clearance of 
adrenaline to 55 per cent. 
(tj , 
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(3) Influence of Ascorbic Acid. CFI 0 . 
Ascorbic acid is a strong reducing substance. 
It oxidizes itself in the air, particularly when it 
is in the form of salt, or in a feebly alkaline 
solution; but at pH 7 only if some oxidative 
catalyst be present, such as copper. It is more 
stsble in a faintly acid medium,. 
Ascorbic acid is well known to act as a 
stabiliser of adrenaline in vitro by virtue of its 
reducing property. Baca (ln6 a ) found that the 
oxidation of adrenaline in vitro was inhibited by 
ascorbic acid in concentrations of 0.01 to 0.1 per 
cent. Ezent Gyorgyi (1928) showed that ascorbic 
acid, in a concentration of 0.0025 per cent., was 
sufficient to delay in vitro oxidation of adrenaline 
by the peroxidase system. 
The destruction of adrenaline by isolated 
tissues has also been found to be influenced by 
ascorbic acid. Clark and Raventos (1239 ) 
calculated that the inactivation of adrenaline by 
auricular strips was reduced to one fourth by the 
addition of ascorbic acid in a concentration of 
0.0001 per cent. (10 ). 
The/ 
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'me potentiation of adrenaline action has 
also been demonstrated by Schupfer (1940) . rie 
found that the mydriatic action of adrenaline on 
the isolated frog's eye and the isolated iris of 
the ox was increased after the addition of ascorbic 
acid in a concentration of 0.05 per cent. The 
maximum effects were obtained at 0.1 per cent. 
concentration of ascorbic acid. elch (1934) 
concluded that reducing substances such as 
glutathione and ascorbic acid normally present in 
the body, are in sufficient concentration to prevent 
the destruction of adrenaline from direct oxidation 
by molecular oxygen, but they do not prevent its 
destruction by enzymes in the animal organism. The 
results obtained in vitro by various investi a.tors. 
indicates that an auto- oxidation, destruction by 
enzymes, and the inactivation by the isolated tissues 
are prevented by ascorbic acid.On the other hand, 
the destruction of adrenaline in vivo is not affected 
by ascorbic acid at all. 
Bacq (1936 a ) and later Clark and Raventos 
(1939) found that the intravenous injection of 
ascorbic acid neither prolonged the duration nor 
increased the amplitude of the response of n.m. 
or/ 
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or blood pressure to adrenaline. The former 
author suggested that the ineffectiveness of 
ascorbic acid was probably due to its rapid oxidation 
in the body. 
In the following experiments the effects 
of large doses of ascorbic acid given as single 
injection crcontinuous infusions on the action 
and clearance of adrenaline have been investigated. 
In addition,the ascorbic acid content of the n.m. 
was estimated chemically in order to find out whether 
the injection of ascorbic acid increased its content 
in the n.m. at the time of the experiment. 
Cats were prepared as for the previous 
experiments and the methods employed were the same 
as for pyrogallol and cocaine. Single injections 
of adrenaline in increasing doses were first given 
and the responses of the n.m. and blood pressure 
were recorded. This was followed by continuous 
infusions of adrenaline. hscorbic acid 
(neutralized to pH 4) was either given as a single 
injection (about i gram per kg.) or continuous 
infusions (20 to 40 mg. /kg. /min.). 
of/ 
In cases 
of continuous infusions of ascorbic acid, the 
adrenaline injections were not started for about 4 
minutes. These continuous ascorbic acid infusions 
were kept running until the effect of the adrenaline 
injected was over. 
Fig. 32 shows that ascorbic acid caused no 
measurable change in the height of the response to 
either single or continuous adrenaline injections. 
Neither was the duration of the response of the 
blood pressure or n.m. to single adrenaline 
injections affected (Fig. 33). 
and 34b 
In Fig. 34a are shown the tracings of the 
responses of the n.m. and blood pressure to a 
continuous dose of 5.53 µg /kg. /min. adrenaline 
(A) before ascorbic acid, (B) simui.teau6ly with 
a continuous dose of about 38 mg /kg. /min. ascorbic 
acid. It can be seen that the height of the 
plateau response and time required for recovery 
when adrenaline is stopped are practically the 
same before and with ascorbic acid injection. The 
ascorbic/ 
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ascorbic acid content of the n.m. was 0.1 mg. per 
100 mg., whereas the n.m. of the other side removed 
before ascorbic acid injection contained 0.011 mg. 
per 100 mg. of ascorbic acid. 
Estimation of ascorbic acid in the n.ictitatin& 
membrane of the cat. 
The method used was the modification of the 
micro- method for estimation of ascorbic acid in the 
blood described by Farmer and Abt (1936). The n.m. 
was removed, weighed on the torsion balance, cut 
into small pieces and transferred to a test tube 
containing 5 c.c. of 10 per cent. acetic acid. 
This was then ground and centrifuged. To 2 c.c. of 
the supernatant fluid,2 c.c. of freshly prepared 
5 per cent. metaphosphoric acid was added. This 
was again centrifuged and 2 c.c. of supernatant 
fluid were titrated against dichlorphenol indo- 
phenol (2 tablets, each tablet of the titration 
value equivalent to 1 mg. of ascorbic acid). The 
dichlor- indophenol was run in from a Conway burette 
into the solution and then kept stirred by a stream 
of carbon dioxide. A blank titration in meta- 
phosphoric acid and water was done and allowance 
was made for it in the calculation. 
In/ 
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In the case of the n.m. after administration 
of ascorbic acid, the solution Aiediluted again, 
with metaphosphoric acid before the titration and 
allowance was made in the calculation. The 
results of 9 experiments ere given. in Table 18. 
The normal quantity of ascorbic acid found was 
about 0.01 mg. per 100 mg. The high values in the 
preliminary experiments nos. 4 and 5 are obviously 
due to some experimental errors. The table 18 shows 
that the single injections or continuous infusions 
of ascorbic acid produce an increase in the 
quantity of ascorbic acid in the n.m. depending on 
the quantity administered. 
The maximum concentration found as the 
result of ascorbic acid injection was 0.15 mg. per 
100 mg. Control tests were made to exclude the 
possible effects of adrenaline alone on the 
ascorbic acid content of the n.m. This shows that 
adrenaline has no effect on the reducing agent 
content (ascorbic acid) of the n.m. 
_Cg_ 
VI. DISCUSSION. 
The results of the experiments show that the 
height and the duration of the nictitating membrane 
and blood pressure responses to adrenaline are 
increased by cocaine. The responses of the 
nictitating membrane to adrenaline in doses above 
15 mg. /kg. ere, however, diminished instead of 
being increased when doses of cocaine exceeded 
3 mg/kg. 
Burn and Tainter (1931) observed that the 
inhibition of the uterus of the virgin cat caused . 
by adrenaline was reduced by cocaine. r,iecgregor 
(1939) found that low concentrations of cocaine 
potentiated whereas high concentrations inhibited 
the action of a r.eneline on the isolated uterus of 
the cat. More recently Tripod (1940) showed 
that local anaesthetics, namely, butyne, perceine 
and stovaine,possessed sympathomimeti.c action,snd 
like cocaine, were capable of modifying the action 
of adrenaline either by potentiating or by 
inhibiting its action. 
Curtis (1929) found that ephedrine when 
given/ 
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given in large doses, diminished the blood pressure 
response to adrenaline in the chloralosed cat, 
Later Gaddum and Kwiatkowski (1938) showed that 
ephedrine in small doses potentiated the nictitating 
membrane response to adrenaline and to the nerve 
stimulation. They advanced a theory to explain 
this ephedrine and adrenaline potentiation and 
antagonism. According to this hypothesis, 
ephedrine augments the action, by attaching itself 
to the molecules of the enzyme which destroys c.dren- 
aline. The inhibition on the other hand is brought 
about by the attachment of ephedrine to the 
sympathetic receptors of the cells, which makes 
them inaccessible to edreneline. 
Cocaine is not chemically related to 
sympathomimetic amines, but it has a weak sympatho- 
mimetic action like ephedrine. By virtue of this 
property it may augment or inhibit the action of 
adrenaline in a manner similar to that of ephedrine 
as described by Gaddum and Kwiatkowski (1938). The 
reduction in the rate of inactivation can be 
accounted for as due to the inhibition of the 
enzyme concerned. The rate of clearance of 
adrenaline was reduced to 55 per cent. after cocaine 
and to about 40 per cent. after pyrogallol. These 
drugs/ 
drugs, however, did not disturb the relation 
found, i.e. the continuous dose varies as 
(quick dose)2 /3 . The maximum dose of continuous 
adrenaline änd the corresponding amount of cumulation 
which produced plateau effect were found to be 
reduced after cocaine or pyrogallol administration. 
This suggests that after pyrogallol end cocaine 
enzyme saturation takes place earlier than in the 
absence of these drugs; this is probably due to 
the inhibition of the enzyme by these two drugs. 
Bacq (l936 a ) found that ascorbic acid neither 
prolonged nor intensified the action of adrenaline 
in vivo. He ascribed the failure of ascorbic 
acid to influence the action of adrenaline to its 
rapid-oxidation in the body. In order to verify 
this explanation of Baca (lá36 a ), the quantitative 
estimations of ascorbic acid in the nictitating 
membrane of the cat before and after its adminis- 
tration were made. The results show (Table 18) 
that ascorbic acid in the reduced form increased 
in quantity in the nictitating membrane as the 
result of its administration and that it is not 
oxidized as rapidly as suggested by Bacq. 
The destruction of adrenaline through various 
agencies/ 
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agencies in vitro (by auto oxidation, destruction by 
enzymes (peroxidase) and inactivation by various 
isolated tissues) has been shown by many investi- 
gators (Bacq, 1936a; Lzent Gyorgy i, 1928; Clark 
and Raventos, 1939; and :;ch.upfer, 1940) to be 
inhibited by ascorbic acid in concentrations ranging 
from 0.0001 to 0.1 per cent. 
As is seen in the present experiments ascorbic 
acid does not seem to have any inhibitory effect on 
the inactivation of adrenaline in vivo, even when its 
concentration in the tissue tested (nictitating 
membrane) is raised to the limit (0.15 per cent.) 
which is sufficient to be effective in vitro. It 
seems reasonable therefore to conclude that 
adrenaline is probably inactivated in vivo by some 
enzyme system which is not affected by ascorbic acid. 
This supports the view that adrenaline inactivation 
in vivo is brought about by amine -oxidase, the action 
of which in vitro is not inhibited by ascorbic acid. 
But recently Richter (1940) and Richter and 
Mackintosh (1941) have shown that adrenaline 
administered by mouth in man and rabbits is 
inactivated in the body by the process of conjugation 
with sulphate, and about 70,c of adrenaline in this 
form/ 
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form is excreted in the urine. The enzyme system 
taking part in such a process (:ulphosynthase) 
appears to be inhibited by cocaine and pyrogallol 
but not by ascorbic acid. The inactivation of 
adrenaline in vitro by some isolated tissues,however, 
seems to be a different process from that in vivo,as 




1. Continuous infusion of adrenaline in the cat 
produces over a wide range of doses a plateau 
response both in the nictitating membrane and 
blood pressure. 
2. This indicates that enzyme saturation does not 
occur even with large doses (correction of conclusion 
of Clark and Raventos, 19394). 
3. The relation between the continuous and equi- 
valent quick dosage shored that the amount cleared 
per minute varied as (concentration present) /3. 
4. Such a form of clearance was also found by 
dosage- duration relation as it showed a linear 
relation between (dose)16 and the duration of 
action. 
5. The mathematical calculations of the course of 
cumulation and clearance of adrenaline made by 
means of the formulae derived from the above 
relation approximate with the observed results. 
6. Mathematical methods calculating the clearance 
of adrenaline from its pharmacological effects on 
the/ 
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the blood pressure and nictitating membrane of cat 
have been used to study the effects of drugs which 
inhibit its destruction. 
7. The rate of clearance of adrenaline calculated 
was diminished to about 40 per cent. by pyrogallol 
and to 55 per cent. by cocaine, but was not 
affected by ascorbic acid. 
8. Large doses of cocaine inhibited the effect of 
large doses of adrenaline on the nictitating 
membrane. 
9. None of the enzyme inhibitors tested altered 
the relation found, i.e. continuous dose of 
adrenaline varies as (quick dose)/ . 
10. The failure of ascorbic acid to prolong the 
action of adrenaline was not due to its destruction, 
since its presence in the tissues in adequate 




I am greatly indebted to the late Professor 
A.J.Clark, under whose kind guidance the major 
part of this work was carried out. I also wish. 
to thank Professor J.N. Gaddum amd Dr J.N?. Robson 
for their help and suggestions during the course 
of this research. The expenses for the animals 
and drugs were defrayed by a grant from the IVoray 
Research Fund of the University of Edinburgh, for 
which I express my thanks. 
-76- 
VIII. BIBLIOGRAPHY. 
Abel, J.J. (1897 -98). Johns Hopkins Hosp. Bull. 9,215. 
Aldrich, T.B. (1901). .Amer.J.phySio1 S 457. 
Ansari, M.Y. (1942). quart. J. exp. ihysiol. 31,161. 
Bacq, Z.M. (1938a). Arch. Int. Physiol. 42, 340. 
Idem. (19360.J. Physiol. 87, 87P. 
Idem. (19360). Arch. Int. rhysiol. 44, 15. 
Idem. (1938). J. rhysiol. 92, 28r. 
Bacq, Z.M. and Fredricq. (1935). Arch. Int. rhysiol. 
40,297. 
Bain, W.A., Gaunt, W.E. and Suffolk, S.F. (1936a). 
J. Physiol. 87, 8P. 
Bain, W.A. and Suffolk,S.F.(1936b) Ibid. 86, 34r. 
Bain, W.A., Gaunt, W.E. and Suffolk, S.F. (1937). 
J. Physiol. 91, 233. 
Barger, G. and Dale, H.H.(1910). Ibid. 41,19. 
87 
Barger, G.and Jowett (1905). Trans. Chem. Soc4,967. 
Barker, J.H., Eastland , C.J. and Evers, N. (1932) 
Bioc1 em. J. 26, 2129. 
Battelli (1902). C.R.Soc. Biol. 54, 1518. 
Bayer/ 
-77- 
Bayer, G. and Wense, Th. (1938). Arch. Int. Pharma- 
codyn. 58, 103. 
Beyer, K.H. (1941). J. Pharmacol. Exp. Therap. 71,151 
Beyer, K.H. and Vernon,Lee W. (1942). Ibid. 74,155 
Bhagvat, K., Blaschko,H. and Richter, D. (1939). 
Biochem. J. 33, 1338. 
Bhagvat, K. and Richter, D. (1938). Ibid. 32,1397 
Blaschko,H., Richter, D. and Schlossmann, H. (1937a) 
J. Physiol. 90,1. 
Blaschko, H. et al. (1937b) Ibid. 89, 39P. 
Blaschko, H. and Schlossmann,H. (1940). Ibid. 98,130.. 
Blix, G. (1929). Skand. Arch. rhysiol. 56, 131 
Burn, J.H. and Tainter, M.L. (1931). J.Physiol. 71,169 
Carnot, P. and Josserand,P.(1902). C.R.So.c Biol, 
54,14 ̂r2. 
Clark, A.J. and Raventos, J. (1939). Quart. J. exp. 
Physiol. 29,185. 
Cramer, W. (1911). J. Physiol. 42, 36. 
Curtis, F.R.(1929). J. Pharmacol. exp. Therap. 35,333 
Dakin/ 
-78- 
Dakin. (1905). croc. Hoy. Soc. B.'76, 491. 
De VOS,J+ kochmann,M. ( 1Qo5 ).Arch.Int.Phârm2codyn.14,81. 
Dragstedt, C.A., Jrightman, H.H. And Hoffman, J.W. 
(1928) Amer. J. Physiol. 84, 307 
Duchateau-Bosson, G. and Florkin, M. (1939). C.R.Soc 
Biol. 132, 47. 
Elliott, R.T. (1905) J. Physiol. 32, 401. 
Embden, G. and v.Furth,0. (1904). Beitr.Chem. 
- Physiol. 4, 421. 
Farmer, C.J. and Abt, A.F.(1936). .roc. Soc. exp. 
Biol. Med. 34, 146. 
Frolich, A. and Loewi, 0. (1910). Arch. Exp. Path. 
rharmak. 62, 159. 
Gaddum, J.H. and Kwiatkowski, H.(1938).J.Physiol. 
94, 87. 
GeoffridiÓ . (1907) . Biochem. Centr. 6,607. 
Green, D.E. and Richter, D.(1937) Biochem. J. 31,596 
Heard, H.D.H. and Raper, H.S.(1933) Biochem. J. 27, 
36. 
Jackson, D.E.(1909). Amer. J.Physiol. 23, 226. 
Jang. (1940). J. Pharmacol. exp. Therap. 70,347. 
Jowett, (1904). J. Chem. s5,192.. 
'rastle and Loevenhart. (1901). Amer. Chem. J. 20,539 
Keilin/ 
..79 
Keilin, D. (1929). moe. Roy. Soc. B.1O4, 206 
Idem. (1936). Ibid. B.121, 165. 
Keilin, D. and Hartree. (1938) croc. Roy. Soc. 125, 
171. 
Keilin, D. and Mann, T. (1938). croc. Roy. Soc. B.125¡, 
187. 
Kohn, H.I. (1937). Biochem. J. 31, 1593. 
Kretschmer. (1907). Arch. exp. Path. Pharmak. 57,423 
Labate, J.S. (1941). J. rharmacol. Exp. Therap. 72, 
370. 
Langlois. (1897). C.H. Soc. Biol. caris,f 571.: 
Idem. (1898). Arch. rhysiol. Norm. .path. 5 Ser. 
10, 124. 
Lawen,g. (1409), Arch. ExPPath.a.Tharm.5I,415 
Lawrence, W.S., Morton, M.C. and Painter, M.L. 
(1942). J. Pharmacol. Exp. Therap. 75, 219. 
Livon. (1904). C.R.Soc. Biol.p 5391 1118 
Luduena, F.P. (1940). Rev. Soc. Argent. idol. 16,701 
Macgregor, D.F.(1939). J. Pharmacol. Exp. Therap., 
66, 394. 




Niel() de R.H. and Luduena, F.r.(1940). Rev. Soc. 
Argent. Biol. 16, 452. 
Neuberg, O.(1908). Biochem. Z. 8, 383. 
Oliver, G. and Schafer, E.Á.(1895). J.Physiol. 18,2301', 
Philpot, F.J.(1937). Biochem. J. 31, 856. 
Idem. (1940). J. Physiol. 97, 301. 
Philpot, F.J. and Cantoni, G.(1941). J. rharmacol. 
Exp. Therap. 71, 95. 
Prohaska, J.V., Haines, H.P. and Dragstdt,L.R. 
(1937) Ann. Surg. 106, 857. 
Pugh, C.E.M. and Waste', J.H. (1937). Biochem. J. 
31, 286. 
Richter, D. (1934) Biochem. J. 28, 901. 
Richter, D. (1937) Ibid. 31,2022. 
Idem. (1940) J.Physiol. 98, 361. 
Richter, D. and Mackintoshr'(1941) Amer. J.Physiol. 
135,1. 
Richter, D. and Tingey, A.Á.(1939) J.Physiol. 97,265. 
Rosenblueth, A.(1932). Amer.J.Physiol. 101,149 
Idem. (1931). Ibid. 98,186. 
Schild,H. (1933). J.Physiol. 79, 455 
; Schupf er/ 
Schupf er, F.(1940). Bull. Soc. Ital. Biol.Sper. 
15,282. 
Stolz. (1904). Ber. Chem. Ges. 37, 4149 
Sugawara, T.(1928 -29). Tokio J. exp. Med. 12,97 
Szent Gyorgi,A. (1928). Biochem. J. 22, 1387 
Tainter, M.L. (1929). J. rharmacol. exp. Therap. 
36, 569 
Idem. (1930). Quart. J. charm. Pharmacol. 
111, 584 
Idem. (1931) . Arch. Int. rharmacodyn. 
365. . 
Takamine, J.(1901). ATner.J.Pitarmacy.73,5.23. 
Tatum, A.L.(1912). J.Pharmacol. 11xp. Therap. 4,151 
Idem. (1920). Ibid. 16, 109. 
C.H. A.J. 
Thl.enes4 and Hockett.A (1928). croc. Soc. Exp. Biol. 
25, 793. 
Toscano -Alco, J., Malafaya, Baptista, H. (1935). 
C.R.Soc. Biol. Paris, 120, 545. 
Trendelenburg, P.(1916). Arch. exp. kath. Pharmakol. 
79, 154. 
Idem. (1924). Heffter's Handb. exp. 
rharmak. 2, 1192. 
Tripod/ 
-82- 
Tripod, J. (1940). J.Physiol. 97, 289. 
Vulpian. (1856). C.R.43,663. 
Welch, A.de M. (1934). Amer. J.Physiol. 108, 360. 
Weinstein, S.S. and Manning, R.I. (1937). Sci. 86,1 
Wense, Th. (1935). Hoppe Seyl.Z. 260,100. 
Wiltshire, M.P. (1931). J.Physiol. 72, 88. 
Wirt, S.K. and Tainter, M.L.(1932). J.Pharmacol. Exp. 












The effect of quick and continuous adrenaline injections 
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espouse of nictitating membrane to quick injection and 
continuous infusion of adrenaline in 4 sensitive (A) and 














(1)1 0 .49 . 1,1 0.49 0.5 
0.98 2 0.98 2 
1.47 3 1.47 9 
2.94 6 2.9 65 




(2) 0.33 1 0.9 13 
1.0 3 1.8 84 





(3) 0.4 1.75 1.21 36 
1.4 8.5 3.8 93 
4.8 43 3.13 100 
14.4 58 
48.J 114 




.33.8 78 Allbt`.. 
(B) 
(1 0.3 no response 1.8 10 
0.?2 3.8 20 
0.36 II 
3.6 '?,9 
(2) 0.34 no response 0.34 no response 
1.02 1.5 1.02 2 
3.4 7,5 34 5? 
10.2 40 6.8 89 




Efeect of adrenaline on the nictitating membrane and blood 
pressure given as quick as possible and spread over different 








of response in mm. to 




















0.4 10.5 23 23 
4.0 34 1'7 57 27 
33 17.5 6.5 5 30 30 30 30 
0.66 165 17 
3.3 48 39.5 48 49 b.) 
0.36 10 10 
3.6 8 5 13 20 19 20 
.8 11 9 24 
Table 4. 
Continuous adrenaline doses and quick equivalents from 
blood pressure and nictitating membrane response 
(averages from 27 experiments). 
Continuous adrenaline 
,ag /kg. /min. 
Quick adrenaline equivalent g /kg. 



















Continuous adrenaline doses and quick equivalents from 
blood pressure and nictitating membrane response. 




Quick adrenaline equivalent (,ug. /kg. ) 


















Duration of response of nictitating membrane to 




Duration of nictitating 




















Duration of response of nictitating membrane to quick 
adrenaline injections. (Averages of 8 experiments) 
Dose of adrenaline 
.,c4.6/kg, 
Duration of nictitating 



















(a) continuousAg /kg. /min. 

































valents of (a) 0.5 0.5 1.2' 3.8 19 28 60 
(b) 1.2 2.2 3.0' 14 50 70 110 




g /kg. /min. 
,dditional dose 
g /kg. 
Value of additional dose 
g /kg. calculated from 
response. 
0.33 1.02 1.5,1.3 
3.4 1.7 
0.5 1.5 0.4, 2.5 
0.53 5.0 5.0 
11.5 11.7 
0.66 3.3 2.3 
1.0 3.4 3.53, 1.0 
5 7 
1.5 15 18 
1.66 6.6 8.7 
1.79 11.5 12.92 
2.66 10 16 
3.4 10.2 10 
4.0 10 15 
5.0 10 29 
15 100 
5.3 11.5 21.9 
6.8 10 45 





Amplitude of the response of nictitating membrane to quick and 
continuous injections before and after pyrogallol administration 
(4 experiments). 






























3.32 1 - 0.346 1 23.5 




J.29 1.5 - 0.35 5 
0.88 4 3.5 3.5 110 
2.93 18: 
8.8 45 92 
9.3 82 
3.23 1 - 0.26 1.5 11.5 
J.69 2 2.5 2.65 4 "i 11'7 
2.3 2` - 
6.9 5E 10 
23.0 90 - 
4 0.33 0.5 2.5 0.14 J.5 3 
0.99 1.5 12 J.44 2;,5 22 
3.3 22.5 64 1.48 55 91.5 
9.9 59 107 
33.3 94 115 
Table 11. 
Continuous adrenaline doses and quick equivalents 
before and after pyrogallol. (averages of 8 experiments) 
Continuous 
adrenaline 




0.26 0.4 2.04 4.4 5.0 





Duration of nictitating membrane response to quick adrenaline 
doses before and after pyrogallol from the averages of the 
number of observations given in bracket. 













0.31 2.7 0.3 3.5 
(4) (3) 
o.9 3.1 0.86 5.95 
(7) (6) 
3.0 5.46 2.64 9.52 
('7) (6) 
9.03 8.5 9.1 20.25 
í7l (6) 





























Amplitude of the response of nictitating membrane to quick 
and continuous adrenaline injection before and after cocaine 







































































































Response of the blood pressure to quick and continuous adrenaline 






Response blood pressure 









Plateau response of 
blood pressure to con - 
tinuous adrenaline 









1 0.31 11.5 0.416 10 33 
0.93 12 22 0.138 - 16 
3.1 22 44 1.38 = 51 
9.3 52 - 
31.0 71 - 
2 0.39 9 8.5 0.174 - 17 
1.17 - 9.5 0.5 12 27 
3.9 19 1.74 39 
11.7 37 
39.2 63 
3 0.35 6 13 0,46 - 
1.05 11 20 4.6 - 
3.5 34 22 
10.5 58 - 
35.0 82 - 
0.04 5 5 
0.12 6 - 
0.4 10 7 
1.2 15 
4.08 40 26 
12.2 55 60 
40.8 69 79 
5 0.028 - 6.5 0.038 - 4 
0.089 --- 7.5 0.114 - 17 
0.289 7 13,6.5 0.38 - 38 
0.86 7 20 1.14 - 52 
2.189 30 38 . 
8.67 59 54 
28.9 69 81 





63.4 - 89 
7 0.312 7 10 1.35 47 
0.936 14 22 4.07 r " 83 
3.12 36 39 
9.36 60 38 
31.2 80 63 
1 
Table 16 
Continuous adrenaline and quick equivalents 
before and after cocaine administration. (Averages 
of 5 ex eriments with nictitating membrane response) 
Continuous adrenaline 
kg /kg. /min. 0.2 0.53 1.8 3.6 5.0 
Equivalent of 
quick dose ,ag /kg. 
before cocaine 0.66 4.4 13.1 28.1 
Equivalent quick dose 
g /kg. /after cocaine 3.44 2.8 17.7 
Table 17 
Duration of nictitating membrane response to adrenaline doses 
before and after cocaine from the averages of the number of 
observations given in the bracket. 

















































tration of as- 
corbic acid 
-fter adminis- 






mg.iG mg. A 
1. 0.011,0.01 none 
2. 0.015, 0.016 none 
3. 0.016 0.036 320 Continuous 
intravenous 
4. 0.06 J.05 327 do. 
5. 0.04 0.08 637 do. 
6. 0.009 0.12 645 do. 
7. 0.01:. 0.15 620 do. 
8. 0.011 J.15 673 Single, intravenous 
9. 0.011 0.1 563 do. 
Note: In experiments 1 and 2 adrenaline was injected between 
the removal of the n.m. This had obviously no effect on 


















































































































































Fig. 2a, Responses of the n.n. and blood pressure to 
quick adrenaline doses. 
--0--coL
d 
Fig. 2b. Responses of the n.m. and blood pressure 
to continuons infusion ofg:i ,g /kg /min. 

























Fig_:. 2c. Respónses of the n.m. and b.1ood pressure to 
continuous adrenaline infusion oli. -ry /kg /min. 




















































Fig. 2d. Responses Of the n.m. and blood pressure to 
continuous adrenaline infusion o466,4g /kg /min. 
The. infusion was stopped at S. 

Fis. 3a. Responses of the n.nr. and blood pressure to 
quick adrenaline doses. 
FiG
.3 
Fig. 3b. Responses of the blood pressure and n.m. 
to continuous adrenaline infusion of 4.07 




















F'ig..4b. Plateau response of'the n.m. to continuous 
dose of 6.02 ccg /kg /min. adrenaline administered 
for 19 rniná. The gap in the figure shows an 
interval of 12 mins. The infusion was stopped 
at S. 








i , ,. 
Fib. 5. r:ffects produced on the nictitating mem- 
brane and blood pressure of cat bar quick (A and B) 
and continuous (Al and Bi) doses of adrenaline. 
Figures from 6 experiments given in Table 1. 
Abscissa: log dose µg/kg. or µg/kg. /min. adrenaline 
Ordinate: height of response of nictitating membrane 
or blood pressure. 
The dotted line shows where the curve drawn to 
the formula x 1/k = j /lDC) -y, deviates from the 
observed value. The value of maximum response 
both for blood pressure and n.ii. = 100 mm. and k 
15 and 7µg /kg. for curves A and B respectively. 
E 
z 
Fib 6. Effects prodúced by quick (A and B) and 
continuous (A1 and B1) doses of adrenaline. A and 
Al figures from 4 sensitive cats (Table 2a) and 
B and B1 figures from 2 insensitive cats (Table 2b). 
Abscissa; log. dose µg /kg. or µg /Kg /min. 
Ordinate ;. height of response of n.m. in mm. 
The dotted line shows where the curves drawn to 
the formula x,.. 1/k = ÿ' /100 -y deviate from the 
observed values. 
Maximum response = 150 mm. and values of k = 10 
and 31 p,g /kg. 
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Fig, i« : Re_spOnse of the n.m. and blood pressure to 
continuous dose of '1.0.1 .,tg /kg /miri: adrenaline. 
At quick . adren.aline dose (12.6 
l' 
g /kg,m n..\) was 
administered which produced an extra re onse. 
Blood pressure shows a lowering of the 
level during the period of infusion. At S, the 







Fi 8. Relation between log continuous dose 
µg kg. /min. (abscissa) and log quick dose pg /kg. 
(ordinate) of adrenaline which produce equal 
effects. Averages from 27 experimente (Table 4) 
Crosses: nictitating membrane. 





Fie. 9. Relation between log, continuous dose 
kg./min. (abscissa) and loe. quick dose ilg/kg. 
(ordinate) of adrenaline which produce equal 














































































































































































































































































































































































































































































































































































































































































































































































































































































































MIL ...12. Observed and calculated course of 
response to continuous infusion of adrenaline. 
Abscissa: time in minutes; ordinates: left, 
height response n.m. ; right, adrenaline dosage 
producing corresponding height of response. 
Continuous line; response produced by 3.4 tg /kg /min. 
adrenaline for 10 mins.; dotted line: (A) calcul- 
ated response if no clearance; (B) calculated 
response according to formula 
1 
dx = dt ( k = 0.39) (C) calcul- 
b _kx 2/ 3 
ated fall according to formula 
- 3 (k3 
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Fig. 14. Observed and calculated course of 
response to a large continuous dose of adrenaline. 
Abscissa: time in mins. ; Ordinate; left, the 
height of response n.m.; right, adrenaline dosage 
producing corresponding height of response. 
Continuous line: response produced by continuous 
adrenaline dose of 6.02 µg /kg /min. given for 19 
minutes. 
Dotted line A: response produced if no clearance; 
B, calculated response according to formula 
1 dx = dt where the value 
b -kx2/3 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 16 a. Effect on the n.m. 
and blood pressure 
produced by quick ádreriiline injection. 
Ori-611,1111,11,10)irtni11711711111.1ittilitiliti 
'15:y/6-77- 
6.)116-77'8. E. y//7-/ ,, 
t I 
Oft** op t ' 





: _l , íi.' 
Fig. 16 b Effects produced by gA ck adrenaline 
(11.5,0g /kg.) qdministered during 9.53 µg /kg /min. 
continuous infusion of (the drug. 
Fi 16 b2.= Effects produced by quick adrenaline 
(11.5 µg/kg. administered during 1.79 

















Fig. 16,c. Effects produced by quick adrenaline 
(11.5,(,ßg /kg.) admiñi;Aered during5.3 
iz/kg/min. infusion of the drug. 
FI G. e. 
1T 
2 o 






Fi . 17. Effects produced by quick injections of 
a rena ine superimposed on continuous infusion 
(from Figs. 16b,iand 16c). Abscissa: log. dose 
µg /kg. or .g /kg. /min. Ordinate: height of response 
of n.m. Continuous line and dots: dosage response 
curve to quick injections; crosses: response to con- 
tinuous injection; figures and circles; amount of 
superimposed quick injection and height of response. 
d oSC IWF CC0ICLLR9 im 
111111111111111111111111 11111111111111111111111111111111 
Iiiiiiiiiiiiii iiiiiiiii iiiiiiiiiiiiiiiiiiiiiiiiiiilliiii MOMMEMIMMEMEMMEMMEMMEMM,MMUMMEMMOMMUM =NM ME UMMIN MUM 
MidEMENINIUMMIUMIUMMUIVIIIIIIHMITIMEMII MEMO= MEOW MMOMMEMM MEMMIIIMMEMOMMEMMUMEMMEM EMT= MINTIMM MIMI 
I i 
IIMMINOMMI MEMMIMMERNMEMM 11211MMEMM ME AIM 1111111N WI MOM MUM= ME IMMEMEMINI EMMEMMEMMEMMOAMME =WM MU =MOM 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
Fig.19. Effects produced by quick doses of adrena 
il ne. A, before pyrogallol; B, after pyrogallol, 
and continuous adrenaline before pyrogallol Al, and 
after pyrogallol B1, from 4 experiments. 
Abscissa: log. dose µg /kg. or µg /kg /min. 
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pig. 22. Observed course of n.m. response and Q 
-78143' calculated cumulation and clearance after pyrogallol 
administration. 
Abscissa: time in min,; ordinates: left,height 
of response of n.m. in mm., right, adrenaline dosage 
producing corresponding heights of response after 
pyrogallol; continuous line, response produced by 
1.09 µg /kg /min. adrenaline after pyrogallol; dotted 
line (A), calculated cumulation by means of formula 
1 = ;. = dt where value of k = 0.24. 
b - kx33 
Dotted line B1, calculated clearance by means of 
formula: 









Fi . 23. Relation between (adrenaline dose) ©3 µg /kg! 




Fig. 24. Observed and calculated course of response 
to continuous adrenaline injection before and after 
pyrogallol. 
Continuous line (A): response n.m0 to continuous 1.48 
µg /kg /min. adrenaline before pyrogallol; continuous line 
Al response to the same dose after pyrogallol. 
Dotted line B and B1 calculated cumulation before and after 
pyrogallol; C and C1 calculated fall before and after 
pyrogallol. Value of 
3 
= 0.09 (after pyrogallol and 
0018 before pyrogallol). 
Abscissa: time in minutes; ordinates: left, height of n.m. 
response in mm; right I and II, adrenaline dosages (µg /kg) 
before and after pyrogallol respectively producing 
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Fig. 26 The response of the n.m. and blood pressure 
to an intravenous cocaine dose of 2.5 mg /kg. 
FÌ026. 
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sensitivity of the n.m. response to adrenaline. 
Abscissa: log. dose adrenaline pg /kg. 
Ordinate: height of n.m. response in mm. 
Curves B and B1,responses of the n.m. before and 
after 3.9 mg /kg. intravenous cocaine administration. 
A and Al, responses of the n.m. before and after 
5.2 mg /kg. cocaine. 
Fig. 28. Relation between log, dosage of quick and continuous 
adrenaline and n.m. response before and after cocaine (from 
3 experiments). 
Abscissa: log. dose µg /kg. or µg /kg /min.; ordinate, height 
of nom, response. 
A and Al, single and continuous adrenaline before cocaine. 
B and B1, do. do. after cocaine. 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 29. Relation between log. dosage of quick and 
continuous adrenaline and blood pressure response before 
and after cocaine (from 7 experiments). 
Abscissa: log. dose 4g/kg. or lig /kg; /min.; ordinate: height 
of blood pressure response in mm. 
A and Al, single and continuous adrenaline before cocaine,. 
B and B1, single and continuous adrenaline after cocaine 
(dose of cocaine ranged from 1.5 to 3 mg /kg.) 
63 '5T.ß 
ai 
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F. 30. Relation between continuous dose µg /kg /min. 
(abscissa) and quick dose p,g /kg. (or=dinate) before 
cocaine (B) and after cocaine (A). (from averages 
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Fig. 32, Relation between log. dosage of quick 
and continuous adrenaline and n.m. response before 
and after ascorbic acid administration. 
- = quick adrenaline before ascorbic acid. 
0 = do. after do. 
® = continuous adrenaline before ascorbic acid. 





















































































































































































































































































































































































































Fig, 34a. Responses of the n.xr:A.: and blood pressure of cet 
to continuous intravenous infusions- of 5,55/_g /kg /min. 
adrenaline before ascorbic acid administration. 
q 
BP I 
5.5 3q 9 it min. 
5 Sec. 
FIG34u. 
Fig. 34b. Responses of the n,m. and blood pressure of 
cat to continuous intravenous infusion of 5.53 µg /1r ,/ 
min. adrenaline, when 37.64 mg /kg /mine administration 
of ascorbic acid was started about 6 min. before and 
continued throughout the course of the response._ 
'qt7 
